Diabetes meetings & conferences

7th International Conference on Advanced Technologies & Treatments for Diabetes

February 5-8 2014 Vienna, Austria

Filling a unique niche, the 7th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2014) will attract an international audience of researchers and clinicians as well as developers from the medical technology industry.

Since the inaugural ATTD meeting in 2008, ATTD gatherings have grown dramatically. ATTD 2014 will build on the success of previous annual meetings and present the latest technological advances in treatment of diabetes and related conditions.

Join us for ATTD 2014 in majestic Vienna, Austria, February 5-8 2014 for unparalleled access to unique scientific knowledge as well as valuable networking opportunities.

Contact Us

c/o Kenes International
1-3 Rue de Chantepoulet
P.O. Box 1726
CH-1211 Geneva 1, Switzerland
Tel: +41 22 908 04 88, Fax: + 41 22 906 9140
E-mail: attd@kenes.com
Website: www.kenes.com/attd

34th Anthropology and Health Conference

Anthropology and Personalised Medicine: Impacting the Future of Comprehensive Healthcare

8th-12th September 2013, Inter University Centre, Don Frana Bulića 4, 20 000 Dubrovnik, Croatia

Objectives:

1. To delineate anthropological perspectives on biological constructs of diversity such as “race” and their historical and current impact on the development and practice of personalized medicine.

2. To delineate anthropological sociocultural constructs of diversity such as racism and ethnocentrism, bioethics, health equity and disparities and their historical and current impact on the development and practice of personalized medicine.

3. To examine anthropological contributions to the molecular genetic, population genetic and epigenetic foundations of personalized medicine using Croatian populations as an exemplar.

4. Through the dual lenses of medicine and anthropology discuss new developments and projected epidemiological impact of personalized medicine on metabolic syndrome, diabetes, cancers, forensic sciences, and other diseases and conditions.

5.To develop a comprehensive approach to the dissemination, tracking and assessment of the impact of the conference using the Becker Model.

International Society of Nutrigenetics and Nutrigenomics 7th Annual Scientific Meeting (ISNN 2013)

October 5-8, 2013 Quebec City, Canada

Discover the latest findings on nutrigenetics and nutrigenomics as they relate to obesity, aging, cancer, diabetes and its cardiometabolic factors, inflammation and oxidative stress as well as translation into nutrition and personnalized medicine.

Session Themes

• Obesity, healthy body weight: implications for weight management

• Nutrigenetics of aging and cancer

• Inflammation and oxidative stress

• Type 2 diabetes and cardiometabolic risk factors

• Translation of “omics” into clinical practice

Conference secretariat

INAF – Université Laval
Pavillon des Services – Suite 1705
2440 Hochelaga Blvd.
Québec QC Canada G1V 0A6

Tel: 418-656-2131 x12564
Fax: 418-656-5877
info@isnn2013.org

5th International Conference on Fixed Combination in the Treatment of Hypertension, Dyslipidemia and Diabetes Mellitus

21-24 November, 2013 Bangkok, Thailand

Fixed combination has recently made a comeback as an initial therapy in the treatment of hypertension. The additive or synergistic effect of combination therapy fully lowers blood pressure in patients who tend to have less than full response to one component only. Antihypertensive monotherapy does not address the multifactorial nature of hypertension as a disease with many pathways; using more than one drug makes more therapeutic sense, as combined agents cover more than one etiology.

Importance of anti-diabetic and anti-lipidemic combinations should be emphasized as well: Many patients with diabetes mellitus may also be treated with dual pharmacological therapy as fixed combination: two or more drugs acting on different pathophysiological process is often  necessary to reach  early and sustained achievement of individualized  glycemic targets. At the same time choosing the safest option to avoid hypoglycemia is of paramount importance compared with loose pill, both statin and anti-diabetic combination therapies may also have better adherence, improved satisfaction and lower drug costs.

The conference is intended for experts in the fields of diabetes, hypertension, dyslipidemia, internal medicine, cardiology, endocrinology, nephrology, hyperlipidemia, family medicine, primary care physicians, nurse practitioners and physicians’ assistants. All are invited to explore the current and future role of fixed combinations in the treatment of hypertension, dyslipidemia and diabetes.

List of Topics

•  Treatment Simplification and Compliance

•  FDCs as First Step Treatment

•  FDC in Secondary Prevention

•  FDCs of Antihypertensive and Antidiabetic Drugs

•  FDCs of Antihypertensive and Lipid Lowering Drugs

•  FDC in the Elderly and Very Elderly

•  Ambulatory BP in the Assessment of FDC Efficacy

•  Home BP in the Assessment of FDC Efficacy

•  Combinations with Thiazides. Chlortalidone vs HCTZ

•  ACE Inhibitors  and  Diuretics FDC

•  ACE Inhibitors  and  Calcium Channel Blockers FDC

•  ARBs  and Diuretics  FDC

•  ARBs  and Calcium Channel Blockers  FDC

•  Triple Drug Combinations

•  The Polypills

•  FDCs as Generic Drugs

•  Guidelines

•  FDCs in Different Countries

•  Regulatory Aspects

•  Cost Issues

Contact Us

Conference Organizers

Paragon Conventions
18 Avenue Louis-Casai
1209 Geneva, Switzerland
Tel:  +41 (0)22 533 0948    
Fax: +41 (0)22 580 2953

General Enquiries

Noa Beer-Raveh - Project Manager
fixed2013@fixedcombination.com  
Fax: +41 (0)22 580 2953

4th Arab Diabetes Forum

4-6 September 2013 Cairo, Egypt

Target Audience

Physicians, researchers, nurses, nurse practitioners, dietitians, podiatrists, pharmacists, psychologists, Endocrinologists, Diabetes Educators, People interested in diabetes, People with diabetes, Diabetes health professionals, and other health care professionals.

Theme Areas

1- KOL Meetings for Arab Diabetes Alliance.

2- Diabetes in the Arab World:

•Prevalence / Registry
•Cost / Complications
•Cultural Aspects
•Arabic Guidelines

3- Debates and controversies:

•Safety and Efficacy
•Hypos versus hyperglycemia
•Guidelines: which?

4- Workshops and Education Programs.

5- Updates in

•Understanding pathogenesis
•New therapies
•Diabetic dyslipidemia

World Diabetes Congress

The next World Diabetes Congress will be held at the Melbourne Convention and Exhibition Centre, Melbourne, Australia from 2 to 6 December 2013.

The International Diabetes Federation is the global voice for people with diabetes and those at risk. Twenty years after the World Diabetes Congress in Japan, the Western Pacific Region is again in the global health spotlight and is why we have chosen Melbourne to host the World Diabetes Congress in 2013.

Today, more than a third of all people with diabetes are found in the Western Pacific Region. It is also the region that has the highest number of undiagnosed cases and the highest number of deaths attributable to diabetes.

Up Close and Personalized, International Congress on Personalized Medicine

July 25-28, 2013 Paris, France

Personalized Medicine is revolutionizing the medical world. Understanding and integrating genetic and molecular information with traditional clinical knowledge is the hallmark of this transformation. At present much of the medical practice is based on standards of care derived from the epidemiologic studies of large cohorts that do not take into account the individual’s genetic, proteomic, and metabolic characteristics. Furthermore, in spite of efforts to develop data-driven, expert–based, clinical decision support systems, there are no clear and simple means to disseminate new findings into clinical practice.

Following the great success of the meeting in Florence Italy last year, the main focus of the second Up Close and Personalized Congress is to examine the essential clinical, imaging, genomic, proteomic, metabolomic, pharmacogenomic and biomarker data necessary to predict, prevent and treat major medical conditions concerning metabolism (diabetes and obesity) and cancer. As in the first meeting one of the key themes will be to explore bio-informatic tools, algorithms, decision support systems and other new platforms for disease prediction and better tailoring treatment modeling to the individual patient. Furthermore, we will discuss health policy issues such as barriers for implementing Personalized Medicine, and quality assurance.

Topics

Diabetes
Diagnostics
Health Policy
Imaging
Informatics
Obesity
Oncology

Contact Us

Please do not hesitate to contact us with any questions or queries on Up Close and Personalized – The 2nd International Congress on Personalized Medicine.

Congress Secretariat
Paragon Conventions
18 Avenue Louis-Casai
1209 Geneva, Switzerland
Tel: +41 (0) 22 5330 948
Fax: +41 (0) 22 5802 953
Email: Secretariat@upcp.org

Probiotics, Prebiotics, and the Host Microbiome: The Science of Translation

Wednesday, June 12, 2013 | 7:45 AM - 6:00 PM The New York Academy of Sciences

Presented by The Sackler Institute for Nutrition Science at the New York Academy of Sciences and The International Scientific Association for Probiotics and Prebiotics

In the past decade, researchers have observed a strong convergence of prebiotics, probiotics, and the microbiome in areas of host physiology such as the immune system, metabolism, and neurological function. This 1-day conference will serve as a neutral forum to critically examine the potential population-wide economic and public health benefits of translating this research into innovative functional foods and biotherapeutics for a broad spectrum of conditions including obesity, diabetes, inflammatory and gastrointestinal disease, and malnutrition. Participants will apply the rigorous standards of evidence-based medicine and evidence-based nutrition to evaluate and outline novel research and policy strategies to advance the incorporation of prebiotics- and probiotics-based applications to improve public health.

European Academy of Paediatrics 2013 Congress and MasterCourse

19-22 September, 2013 Lyon, France

The 2013 EAP Congress and MasterCourse, EAP will continue our  mission to train, educate, and update those professionals taking care of children, while at the same time stimulating and allowing the delegates the opportunity to meet and/or create personal professional network of colleagues and friends. The 2013 EAP Congress is the perfect setting to get the most updated, state-of-the-art information on the latest developments in research and clinical practice in the main areas of Paediatrics. It also provide the opportunity to debate on controversial issues and to contribute to the progress of the practice of paediatrics.

Congress Topics

    
Adolescent Medicine
Allergy and Immunology
Critical / Emergency Care
Endocrine & Diabetes
Gastroenterology and Nutrition
Genetic & Metabolic
Hemato - Oncology
Infectious Diseases

Neonatology
Nephrology
Neurology
Obesity
Paediatric Tropical Medicine
Primary Care
Respiratory
Rheumatology

MasterCourse Topics

Gastroenterology
Nutrition

Paragon-Conventions
18 Avenue Louis-Casai
1209 Geneva
Switzerland

Tel: +41 22 5330 948
Fax: +41 22 5802 953
Email: congress@eapaediatrics.eu
http://www.paragon-conventions.com